The Tom Mandel Islet Transplant Program is delivered by a multidisciplinary team.
Professor
Thomas Kay
Director, St Vincent’s Institute of Medical Research (SVI)
Tom’s research interests are autoimmunity, particularly of type 1 (juvenile) diabetes.
Dr Tom
Loudovaris
Islet Isolation
Manager
Tom has been involved in islet transplantation for nearly 30 years. He has worked at Baxter Healthcare and co-founded a cell encapsulation company in the USA.
Dr John
Vrazas
Transplant
Interventionist
John is a Fellow of the Royal Australian and New Zealand college of Radiologists; a Member of the Society of Interventional Radiology (USA); President of the Interventional Radiology Society of Australasia.
Ms Kathy
Howe
Clinical Nurse
Coordinator
Kathy is a registered nurse and credentialed diabetes educator. In 2009, she joined the team at St Vincent’s Hospital where she assists in the selection of suitable recipients with unstable type 1 diabetes for islet transplantation.
A/Prof
David
Goodman
Nephrologist
SVHM
.
David is in charge of clinical islet and renal transplantation at SVHM. He completed his PhD at WEHI then did postdoctoral studies in Transplant biology at Harvard Medical School. He established the Islet Transplant Clinic at St Vincent’s Hospital.
Professor
Richard
MacIsaac
Director, Endocrinology and
Diabetes Department
SVHM
Richard’s research is focused on diabetes complications.
Professor
Frank
Ierino
Director of
Nephrology
SVHM
Frank’s work in transplantation has been in immune tolerance, immunobiology of the allograft response and xenotransplantation. Cardiovascular Disease in Chronic Kidney Disease is a further area of clinical and laboratory research focus.